WeChat Mini Program
Old Version Features

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer.

Erica L Mayer,Yue Ren,Nikhil Wagle,Reshma Mahtani,Cynthia Ma,Angela DeMichele,Massimo Cristofanilli,Jane Meisel,Kathy D Miller,Yara Abdou,Elizabeth C Riley,Rubina Qamar,Priyanka Sharma,Sonya Reid,Natalie Sinclair,Meredith Faggen,Caroline C Block,Naomi Ko,Ann H Partridge,Wendy Y Chen,Michelle DeMeo,Victoria Attaya,Amanda Okpoebo,Jillian Alberti,Yuan Liu,Eric Gauthier,Harold J Burstein,Meredith M Regan,Sara M Tolaney

Journal of clinical oncology : official journal of the American Society of Clinical Oncology（2024）

Cited 0|Views59
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined